163 related articles for article (PubMed ID: 15998904)
21. Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy.
Bianco R; Troiani T; Tortora G; Ciardiello F
Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S159-71. PubMed ID: 16113092
[TBL] [Abstract][Full Text] [Related]
22. Targeted therapy for colorectal cancer.
Hwang J; Marshall JL
Curr Opin Investig Drugs; 2006 Dec; 7(12):1062-6. PubMed ID: 17209523
[TBL] [Abstract][Full Text] [Related]
23. Integrating targeted agents into therapeutic regimens for patients with resectable colorectal cancer.
Marshall JL
Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S63-6. PubMed ID: 19064409
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanisms of signal transduction: epidermal growth factor receptor family, vascular endothelial growth factor family, Kit, platelet-derived growth factor receptor, Ras.
Erman M
J BUON; 2007 Sep; 12 Suppl 1():S83-94. PubMed ID: 17935283
[TBL] [Abstract][Full Text] [Related]
25. Integrating new targeted agents into the treatment of non-small-cell lung cancer.
Thatcher N
Lung Cancer; 2006 Dec; 54 Suppl 2():S25-31. PubMed ID: 17056150
[TBL] [Abstract][Full Text] [Related]
26. New mechanisms of signal transduction inhibitor action: receptor tyrosine kinase down-regulation and blockade of signal transactivation.
Lee AV; Schiff R; Cui X; Sachdev D; Yee D; Gilmore AP; Streuli CH; Oesterreich S; Hadsell DL
Clin Cancer Res; 2003 Jan; 9(1 Pt 2):516S-23S. PubMed ID: 12538509
[TBL] [Abstract][Full Text] [Related]
27. Novel targets in gastric and esophageal cancer.
Valverde CM; Macarulla T; Casado E; Ramos FJ; Martinelli E; Tabernero J
Crit Rev Oncol Hematol; 2006 Aug; 59(2):128-38. PubMed ID: 16829119
[TBL] [Abstract][Full Text] [Related]
28. Resistance to epidermal growth factor receptor-targeted therapy.
Morgillo F; Lee HY
Drug Resist Updat; 2005 Oct; 8(5):298-310. PubMed ID: 16172017
[TBL] [Abstract][Full Text] [Related]
29. Predicting response to epidermal growth factor receptor-targeted therapy in colorectal cancer.
Adams R; Maughan T
Expert Rev Anticancer Ther; 2007 Apr; 7(4):503-18. PubMed ID: 17428171
[TBL] [Abstract][Full Text] [Related]
30. Novel targets for pancreatic cancer therapy.
Philip PA
Surg Oncol Clin N Am; 2010 Apr; 19(2):419-29. PubMed ID: 20159523
[TBL] [Abstract][Full Text] [Related]
31. Inhibitors of growth factor signalling.
Wakeling AE
Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S183-7. PubMed ID: 16113095
[TBL] [Abstract][Full Text] [Related]
32. Molecular therapeutic approaches to acute myeloid leukemia: targeting aberrant chromatin dynamics and signal transduction.
Piazza F; Semenzato G
Expert Rev Anticancer Ther; 2004 Jun; 4(3):387-400. PubMed ID: 15161438
[TBL] [Abstract][Full Text] [Related]
33. Angiogenesis, immune system and growth factors: new targets in colorectal cancer therapy.
Fantini MC; Becker C; Neurath MF
Expert Rev Anticancer Ther; 2005 Aug; 5(4):681-94. PubMed ID: 16111468
[TBL] [Abstract][Full Text] [Related]
34. Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways.
Wallerand H; Reiter RR; Ravaud A
Curr Opin Urol; 2008 Sep; 18(5):524-32. PubMed ID: 18670279
[TBL] [Abstract][Full Text] [Related]
35. Molecularly targeted therapies for colorectal cancer: Strategies for implementing translational research in clinical trials.
Zwierzina H; Bardelli A; Ciardiello F; Gariboldi M; Håkansson L; Lambrechts D; Lind GE; Loeffler-Ragg J; Schmoll H; Siena S; Tabernero J; Van Cutsem E
Curr Opin Mol Ther; 2010 Dec; 12(6):703-11. PubMed ID: 21154162
[TBL] [Abstract][Full Text] [Related]
36. Developing novel and highly effective new therapeutic strategies for treatment of colorectal cancer: where do we go from here?
Houghton JA
Curr Opin Investig Drugs; 2001 May; 2(5):674-6. PubMed ID: 11569946
[No Abstract] [Full Text] [Related]
37. In search of novel molecular targets in cancer: the diacyglycerol pathways.
Lorenzo PS
Hawaii Med J; 2004 Oct; 63(10):318-9, 321. PubMed ID: 15570721
[No Abstract] [Full Text] [Related]
38. Targeted therapy: for kids, too.
Corey SJ
Pediatr Blood Cancer; 2005 Oct; 45(5):623-34. PubMed ID: 15704219
[TBL] [Abstract][Full Text] [Related]
39. Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor.
Dancey JE; Schoenfeldt M
Oncology (Williston Park); 2003 Jun; 17(6):819, 826-30, 833-4 passim. PubMed ID: 12846126
[No Abstract] [Full Text] [Related]
40. Promising new agents for treatment of patients with colorectal cancer.
Von Hoff DD
Semin Oncol; 1998 Oct; 25(5 Suppl 11):47-52. PubMed ID: 9786316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
